« BackNanomedicine: Nanotechnology, Biology and Medicine
Article in Press

Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles

  • Anurag Gupta, BS

      Affiliations

    • PDT Center, Buffalo, New York, USA
  • ,
  • Shouyan Wang, PhD

      Affiliations

    • Department of Chemistry, University of Michigan, Ann Arbor, Michigan, USA
  • ,
  • Paula Pera, MSc

      Affiliations

    • PDT Center, Buffalo, New York, USA
  • ,
  • K.V.R. Rao, PhD

      Affiliations

    • PDT Center, Buffalo, New York, USA
  • ,
  • Nayan Patel, BA

      Affiliations

    • PDT Center, Buffalo, New York, USA
  • ,
  • Tymish Y. Ohulchanskyy, PhD

      Affiliations

    • Institute of Lasers, Photonics and Biophotonics, University of Buffalo, New York, USA
  • ,
  • Joseph Missert, MSc

      Affiliations

    • PDT Center, Buffalo, New York, USA
  • ,
  • Janet Morgan, PhD

      Affiliations

    • Department of Dermatology, Roswell Park Cancer Institute, Buffalo, New York, USA
  • ,
  • Yong-Eun Koo-Lee, PhD

      Affiliations

    • Department of Chemistry, University of Michigan, Ann Arbor, Michigan, USA
  • ,
  • Raoul Kopelman, PhD

      Affiliations

    • Department of Chemistry, University of Michigan, Ann Arbor, Michigan, USA
  • ,
  • Ravindra K. Pandey, PhD

      Affiliations

    • PDT Center, Buffalo, New York, USA
    • Corresponding Author InformationCorresponding authors: Roswell Park Cancer Institute, PDT Center, Elm and Carlton Streets, Buffalo, NY 14263.

Received 13 July 2011; accepted 13 November 2011. published online 23 November 2011.
Corrected Proof

Abstract 

We report a novel post-loading approach for constructing a multifunctional biodegradable polyacrylamide (PAA) nanoplatform for tumor-imaging (fluorescence) and photodynamic therapy (PDT). This approach provides an opportunity to post-load the imaging and therapeutic agents at desired concentrations. Among the PAA nanoparticles, a formulation containing the photosensitizer, HPPH [3-(1′-hexyloxyethyl)pyropheophorbide-a], and the cyanine dye in a ratio of 2:1 minimized the undesirable quenching of the HPPH electronic excitation energy because of energy migration within the nanoparticles and/or Förster (fluorescence) resonance energy transfer (FRET) between HPPH and cyanine dye. An excellent tumor-imaging (NIR fluorescence) and phototherapeutic efficacy of the nanoconstruct formulation is demonstrated. Under similar treatment parameters the HPPH in 1% Tween 80/5% aqueous dextrose formulation was less effective than the nanoconstruct containing HPPH and cyanine dye in a ratio of 2 to 1. This is the first example showing the use of the post-loading approach in developing a nanoconstructs for tumor-imaging and therapy.

Graphical Abstract 

Long wavelength photosensitizer (PS) and NIR cyanine dye (CD) were post-loaded to PAA NPs in variable ratios. Among all the preparations, the nanoplatform containing the PS and CD in a ratio of two to one (2:1) showed the best tumor-imaging (fluorescence) and PDT efficacy (six of ten mice [BALB/c mice bearing Colon 26 tumors] were tumor free on day 60). Under similar treatment parameters the PS (HPPH) in 1% Tween 80/5% aqueous dextrose formulation was 20% less effective.

Keywords: Near-infrared fluorescence imaging, Photodynamic therapy, Post-loading, Polyacrylamide nanoparticles

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors declare no conflicts of interest. A part of the technology presented in this manuscript is licensed to Photolitec, LLC, Buffalo, New York.

 Support was received from National Institute of Health grant CA119358 and the shared resources of the Roswell Park Cancer Center support grant CA16056.

PII: S1549-9634(11)00532-6

doi:10.1016/j.nano.2011.11.011

« BackNanomedicine: Nanotechnology, Biology and Medicine